This unknown stock signed an Exclusive Counter-Drone Technology License Agreement

From Emerging Markets Consulting | Ad

Add in the Non-Lethal Low Energy Cartridge as a potential alternative to Police using handguns

And you have a potentially explosive company.

Click here to learn more

CRBU Insider Trading (Caribou Biosciences)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: N/A

Insider Buying (Last 12 Months): $250,027.05

Insider Selling (Last 12 Months): $0.00

Caribou Biosciences Insider Trading History Chart

Caribou Biosciences Share Price & Price History

^$22.79

▼ -0.36 (-1.56%)

As of 10/27/2021 05:00 PM ET

Days: 30 | 90 | 365

Fake meat? This company is cornering the plant-based market

From Stock Trends Today | Ad

This could become one of the greatest growth stories of our lifetimes

This tiny plant-based firm has explosive growth

Get the FREE investor deck

Caribou Biosciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
10/20/2021	Barbara G. McClung	Insider	Buy	9,219	$2.69	$24,799.11
10/12/2021	Steven Kanner	Insider	Buy	114,860	$1.92	$220,531.20
10/11/2021	Ryan Fischesser	VP	Buy	1,746	$2.69	$4,696.74

Insider Buying at Caribou Biosciences?

Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Caribou Biosciences and related companies.

SEC Filings (Institutional Ownership Changes) for Caribou Biosciences (NASDAQ:CRBU)

Caribou Biosciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company	Details
10/22/2021	Strs Ohio	4,400	$0.11M	0.0%	N/A	0.007%

Data available starting January 2016

Caribou Biosciences Inc. is a clinical-stage CRISPR genome-editing biopharmaceutical company. It involved in developing a pipeline of genome-edited, off-the-shelf CAR-T and CAR-NK cell therapies for the treatment of both hematologic malignancies and solid tumors. Caribou Biosciences Inc. is based in BERKELEY, Calif.

Today's Range

Now: $22.79

$21.95

$23.47

50 Day Range

MA: $25.28

$19.16

$30.29

52 Week Range

Now: $22.79

$15.00

$32.65

Volume

216,092 shs

Average Volume

781,907 shs

Market Capitalization

$1.37 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Caribou Biosciences?: Caribou Biosciences' top insider shareholders include:
Barbara G Mcclung (Insider)
Ryan Fischesser (VP)
Steven Kanner (Insider)
Who are the major institutional investors of Caribou Biosciences?: Caribou Biosciences' top institutional shareholders include:
Strs Ohio — 0.01%
Which institutional investors are buying Caribou Biosciences stock?: During the last quarter, CRBU stock was acquired by institutional investors including:
Strs Ohio
During the last year, these company insiders have bought Caribou Biosciences stock:
Barbara G Mcclung (Insider)
Ryan Fischesser (VP)
Steven Kanner (Insider)